Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1992 3
1993 1
1994 1
1996 2
1997 1
1998 2
2000 1
2001 1
2002 2
2004 1
2006 2
2008 1
2009 1
2010 3
2011 3
2012 3
2013 1
2014 1
2016 2
2017 2
2019 1
2020 2
2021 4
2022 4
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis.
Ryerson LZ, Foley JF, Defer G, Cohen JA, Arnold DL, Butzkueven H, Cutter G, Giovannoni G, Killestein J, Wiendl H, Sinks S, Kuhelj R, Bodhinathan K, Lasky T. Ryerson LZ, et al. Among authors: lasky t. Mult Scler Relat Disord. 2023 Apr;72:104561. doi: 10.1016/j.msard.2023.104561. Epub 2023 Feb 11. Mult Scler Relat Disord. 2023. PMID: 36931078 Free article. Clinical Trial.
Real world data (RWD) in pediatrics.
Lasky T, Chakravarty A. Lasky T, et al. J Biopharm Stat. 2023 Nov 2;33(6):875-880. doi: 10.1080/10543406.2022.2152834. Epub 2022 Dec 15. J Biopharm Stat. 2023. PMID: 36519238
Resilience in rural health system.
Lasky T, Samanta D, Sebastian W, Calderwood L. Lasky T, et al. Clin Teach. 2024 Jan 28:e13726. doi: 10.1111/tct.13726. Online ahead of print. Clin Teach. 2024. PMID: 38282472
Selection of cases and controls.
Lasky T, Stolley PD. Lasky T, et al. Epidemiol Rev. 1994;16(1):6-17. doi: 10.1093/oxfordjournals.epirev.a036145. Epidemiol Rev. 1994. PMID: 7925728 Review. No abstract available.
Categorization of COVID-19 severity to determine mortality risk.
Garry EM, Weckstein AR, Quinto K, Bradley MC, Lasky T, Chakravarty A, Leonard S, Vititoe SE, Easthausen IJ, Rassen JA, Gatto NM. Garry EM, et al. Among authors: lasky t. Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):721-728. doi: 10.1002/pds.5436. Epub 2022 May 9. Pharmacoepidemiol Drug Saf. 2022. PMID: 35373865 Free PMC article.
Current needs in pediatric pharmacoepidemiology.
Lasky T, Artaman A, Czaja AS, Maruti SS, Osokogu OU, Verhamme KM, Sobel RE. Lasky T, et al. Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):738-42. doi: 10.1002/pds.3985. Epub 2016 Feb 22. Pharmacoepidemiol Drug Saf. 2016. PMID: 26910571
51 results